European AI Health Platform Qura Raises Pre-Seed

The €1.5 million pre-seed round for Milan-based Qura was led by United Ventures, with participation from Vento and Italian Angels for Growth. The investment is aimed at expanding the company's medical and engineering teams, boosting its AI capabilities, and preparing for entry into additional European markets. Qura's platform is designed to address persistent, subclinical symptoms that affect an estimated one in five adults—such as chronic fatigue, hormonal imbalances, or digestive issues—that often fall below the threshold for a formal diagnosis in traditional healthcare systems. The company's hybrid model provides users with comprehensive blood testing, followed by an AI-driven analysis and a 45-minute consultation with a physician to create a personalized health plan. The founding team combines experience in consumer health, clinical practice, and technology. CEO and co-founder Virginia Gambardella previously scaled Italy's first mindfulness app and served as Head of Operations at digital therapy platform Serenis. Co-founder and CTO Gioacchino Grand is a two-time founding engineer, and Chief Medical Officer Dr. Margherita Gabba brings a decade of clinical experience to oversee medical protocols and AI validation. Qura is entering a growing European health check-up market projected to reach €18.6 billion by 2030. In 2022 alone, EU countries spent €90.4 billion on preventive healthcare, signaling a significant market opportunity for proactive health solutions. Other startups in the European AI-preventative health space include Ahead Health, which recently raised $6 million for its platform that analyzes MRI scans and blood tests. To build trust, Qura emphasizes that doctors remain central to the user experience, with AI serving to enhance efficiency and personalization. The platform is built to be GDPR-compliant and is integrated with local European laboratory networks. For consumer-facing health apps, this approach is critical as HIPAA typically does not apply unless the app is provided by a healthcare entity, making adherence to consumer protection and data privacy laws paramount. Successful consumer health apps often rely on strong user engagement, which can be significantly boosted by integrating with wearable devices. APIs from Apple HealthKit, Fitbit, Oura, and Whoop allow apps to pull in a wide range of biometric data, though developers face challenges with varying data formats and authentication systems across platforms. The longevity and biohacking space is seeing a surge of investment in startups aiming to extend "healthspan." Companies like Altos Labs and Cambrian Bio are exploring cellular reprogramming and metabolic pathways to target the root causes of aging. This aligns with a broader consumer trend of leveraging data-driven insights for proactive health management, a core element of Qura's value proposition. For founders in the digital health space, the journey from developer to CEO requires a deep understanding of not just technology but also fundraising, regulatory landscapes, and building brand credibility. Early-stage funding in European digital health remains strong, with a notable focus on AI-driven diagnostics and preventative care platforms.